sec filing
NE
NASDAQ · NERV
Minerva Neurosciences, Inc.
Healthcare · Biotechnology
$2.20
Down-$0.10 (-4.35%)
Updated Nov 17, 2026, 3:43 AM
SID Score
2.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 28.95M
- P/E ratio
- 2.79
- Dividend yield
- 0.00%
- 52-week range
- $1.96 – $8.80
- Volume
- 142.08K
- Avg. volume
- 3.01M
Price performance · NERV
NERV price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 16, 2026
NERV closed at $2.20 after 21 trading sessions, down 5.17% for the selected period.
- Last close
- $2.20
- Period change
- -5.17%
- Period low
- $2.20
- Period high
- $2.63
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 16, 2026 | $2.30 | $2.32 | $2.18 | $2.20 | 142.08K |
| Nov 13, 2026 | $2.38 | $2.40 | $2.26 | $2.30 | 74.57K |
| Nov 12, 2026 | $2.53 | $2.53 | $2.34 | $2.38 | 79.4K |
| Nov 11, 2026 | $2.55 | $2.58 | $2.455 | $2.56 | 95.7K |
| Nov 10, 2026 | $2.63 | $2.67 | $2.38 | $2.49 | 110.86K |
| Nov 9, 2026 | $2.42 | $2.76 | $2.26 | $2.63 | 348.31K |
| Nov 6, 2026 | $2.32 | $2.44 | $2.20 | $2.42 | 238.04K |
| Nov 5, 2026 | $2.66 | $2.66 | $2.29 | $2.30 | 182.09K |
| Nov 4, 2026 | $2.41 | $2.63 | $2.39 | $2.57 | 308.64K |
| Nov 3, 2026 | $2.37 | $2.48 | $2.29 | $2.35 | 240.55K |
| Nov 2, 2026 | $2.34 | $2.51 | $2.30 | $2.345 | 230.6K |
| Oct 30, 2026 | $2.23 | $2.32 | $1.96 | $2.32 | 394.69K |
| Oct 29, 2026 | $2.25 | $2.445 | $2.20 | $2.24 | 267.56K |
| Oct 28, 2026 | $2.23 | $2.27 | $2.12 | $2.21 | 204.4K |
| Oct 27, 2026 | $2.25 | $2.335 | $2.20 | $2.23 | 239.28K |
| Oct 26, 2026 | $2.30 | $2.35 | $2.18 | $2.20 | 173.15K |
| Oct 23, 2026 | $2.37 | $2.65 | $2.25 | $2.30 | 137.59K |
| Oct 22, 2026 | $2.39 | $2.50 | $2.37 | $2.40 | 121.14K |
| Oct 21, 2026 | $2.53 | $2.59 | $2.39 | $2.39 | 102.62K |
| Oct 20, 2026 | $2.33 | $2.59 | $2.32 | $2.53 | 194.28K |
| Oct 19, 2026 | $2.37 | $2.47 | $2.24 | $2.32 | 118.34K |
Latest NERV news
The latest Smart Investors Daily articles mentioning NERV.
Stock researchResearch & News · SEC Filings
Company
Market Activity
Research & News
Loading stock research…

